PolyTherics Ltd has strengthened its technology platform with the acquisition of Antitope Ltd, a provider of antibody engineering and immunogenicity screening services. It is issuing £13.5 million in new shares to finance the deal. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
